The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
12.70
+0.16 (1.28%)
At close: Dec 5, 2025, 4:00 PM EST
13.00
+0.30 (2.36%)
After-hours: Dec 5, 2025, 7:00 PM EST
The Chemours Company Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for The Chemours Company stock ranges from a low of $13 to a high of $27. The average analyst price target of $17 forecasts a 33.86% increase in the stock price over the next year.
Price Target: $17.00 (+33.86%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for The Chemours Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +2.36% | Dec 3, 2025 |
| UBS | UBS | Strong Buy Maintains $21 → $18 | Strong Buy | Maintains | $21 → $18 | +41.73% | Nov 11, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $18 | Strong Buy | Maintains | $21 → $18 | +41.73% | Nov 10, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $19 → $17 | Buy | Maintains | $19 → $17 | +33.86% | Nov 10, 2025 |
| Mizuho | Mizuho | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +41.73% | Oct 16, 2025 |
Financial Forecast
Revenue This Year
5.98B
from 5.78B
Increased by 3.34%
Revenue Next Year
6.23B
from 5.98B
Increased by 4.20%
EPS This Year
1.01
from 0.57
Increased by 77.07%
EPS Next Year
1.85
from 1.01
Increased by 83.39%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.2B | 6.5B | |
| Avg | 6.0B | 6.2B | |
| Low | 5.7B | 5.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.5% | 8.4% | |
| Avg | 3.3% | 4.2% | |
| Low | -2.1% | -2.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.47 | 2.25 | |
| Avg | 1.01 | 1.85 | |
| Low | 0.77 | 1.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 157.9% | 123.3% | |
| Avg | 77.1% | 83.4% | |
| Low | 35.8% | 41.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.